Uncategorized
AI in Oncology Takes Off, Tackling HIV and Liver Disease, Pharma’s Recent Gains
Some GEN editors were in sunny San Diego covering the hottest research, trends, and products from the American Association for Cancer Research meeting. We kick things off with news from America’s Finest City, particularly around the growing role of AI in oncology. Then we dive into two new research studies. In the first, scientists used CRISPR to identify genes in primary CD4+ T cells that promote or restrict HIV infection. The second study described engineered implantable liver constructs that could eventually serve as a stopgap for patients waiting for donor transplants. Finally, the acquisitions keep coming as Eli Lilly scoops up CAR T cell therapy developer Kelonia for $7B. Also, Revolution Medicines has shared some impressive data from a Phase III trial of its pancreatic cancer drug.
Listed below are links to the GEN stories referenced in this episode of Touching Base:
AACR 2026: A Video Update from San Diego
By Julianna LeMieux, PhD, and Damian Doherty, GEN, April 21, 2026
AACR 2026 Video Update: Cancer Research Edges Toward an AI-Driven Era
By Fay Lin, PhD, and Jonathan Grinstein, PhD, GEN, April 22, 2026
Using AI in Healthcare Ethically by Considering Humanity
By Corinna Singleman, PhD, IPM, November 18, 2025
10x Genomics Unveils Atera Spatial Platform at AACR Meeting
By Julianna LeMieux, PhD, GEN, April 19, 2026
CRISPR Screens Map Human T‑Cell Genes That Promote or Block HIV Infection
GEN, April 20, 2026
Synthetic Biology and Tissue Engineering Grow Liver Tissue In‑Body
GEN, April 20, 2026
StockWatch: Revolution’s Phase III Pancreatic Cancer Data Dazzles Investors, Analysts
By Alex Philippidis, GEN Edge, April 19, 2026
Lilly to Acquire Kelonia for Up to $7B, Expanding Cancer Cell Therapy Pipeline
By Alex Philippidis, GEN Edge, April 20, 2026
Touching Base Podcast
Hosted by Corinna Singleman, PhD
Behind the Breakthroughs
Hosted by Jonathan D. Grinstein, PhD
The post AI in Oncology Takes Off, Tackling HIV and Liver Disease, Pharma’s Recent Gains appeared first on GEN – Genetic Engineering and Biotechnology News.
Uncategorized
Opinion: Dr. Glaucomflecken wants the corporatization of medicine to be national news
Below is a lightly edited, AI-generated transcript of the “First Opinion Podcast” interview with Will Flanary, aka Dr. Glaucomflecken. Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, or wherever you get your podcasts. Get alerts about each new episode by signing up for the “First Opinion Podcast” newsletter. And don’t forget to sign up for the First Opinion newsletter, delivered every Sunday.
Torie Bosch: Will Flanary is better known as Dr. Glaucomflecken. He is social media’s most famous comedian slash doctor, and he’s not afraid of punching up.
Below is a lightly edited, AI-generated transcript of the “First Opinion Podcast” interview with Will Flanary, aka Dr. Glaucomflecken. Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, or wherever you get your podcasts. Get alerts about each new episode by signing up for the “First Opinion Podcast” newsletter. And don’t forget to sign up for the First Opinion newsletter, delivered every Sunday.
Torie Bosch: Will Flanary is better known as Dr. Glaucomflecken. He is social media’s most famous comedian slash doctor, and he’s not afraid of punching up.
Uncategorized
Biotech’s new company model; The super poop behind a startup launch; and more
Biotech’s new company model; The super poop behind a startup launch; and more
Welcome back to another edition of Endpoints Weekly! Earnings season is in full swing, but we had plenty of original reporting and exclusives you won’t find anywhere else this week. Chief among them: Andrew Dunn’s … Read More
Uncategorized
New Hepta blood test could predict GLP-1 response
While GLP-1s like Ozempic and Wegovy are being widely prescribed for weight loss, doctors currently do not have a way to predict if a patient will successfully respond to the drugs.Read More
While GLP-1s like Ozempic and Wegovy are being widely prescribed for weight loss, doctors currently do not have a way to predict if a patient will successfully respond to the drugs.Read More
Illinois’ financial crisis could bring the state to a halt
The final 6 ‘Game of Thrones’ episodes might feel like a full season
New Season 8 Walking Dead trailer flashes forward in time
Mod turns ‘Counter-Strike’ into a ‘Tekken’ clone with fighting chickens
Meet Superman’s grandfather in new trailer for Krypton
Disney’s live-action Aladdin finally finds its stars
Opinion: Dr. Glaucomflecken wants the corporatization of medicine to be national news
Biotech’s new company model; The super poop behind a startup launch; and more
New Hepta blood test could predict GLP-1 response
Spain readies for evacuations as a hantavirus-hit cruise ship heads for the Canary Islands
STAT+: Roche to buy PathAI for $750 million
STAT+: Capricor Therapeutics accuses Nippon Shinyaku of slow-walking plans on Duchenne drug
Illinois’ financial crisis could bring the state to a halt
The final 6 ‘Game of Thrones’ episodes might feel like a full season
New Season 8 Walking Dead trailer flashes forward in time
Mod turns ‘Counter-Strike’ into a ‘Tekken’ clone with fighting chickens
Meet Superman’s grandfather in new trailer for Krypton
Disney’s live-action Aladdin finally finds its stars
-
Uncategorized9 years agoThese ’90s fashion trends are making a comeback in 2017
-
Uncategorized9 years ago
According to Dior Couture, this taboo fashion accessory is back
-
Contributors9 years ago
The final 6 ‘Game of Thrones’ episodes might feel like a full season
-
Uncategorized9 years ago
Uber and Lyft are finally available in all of New York State
-
Uncategorized9 years ago
Phillies’ Aaron Altherr makes mind-boggling barehanded play
-
Uncategorized9 years ago
The old and New Edition cast comes together to perform
-
Uncategorized9 years ago
Steph Curry finally got the contract he deserves from the Warriors
-
Uncategorized9 years ago
Disney’s live-action Aladdin finally finds its stars